EverydayHealthLogo

CD

Dr. Charles C Debattista, MD

Psychiatrist

28 Years of Experience

Accepting patients

    Overview

    Dr. Charles Debattista, MD is a Psychiatrist, who primarily practices in Palo Alto, CA. He has been practicing for over 28 years and is board certified by the American Board of Psychiatry and Neurology and American Board of Psychiatry and Neurology. Dr. Debattista graduated from University of California, completed his residency at Stanford Univ Hosp, Psychiatry, and is currently affiliated with Lucile Packard Children's Hospital. Dr. Debattista is fluent in English and is currently seeing new patients. Dr. Debattista’s practice accepts Medicaid, Bravo Health, Cigna, Aetna, UnitedHealthcare, Blue Cross Blue Shield (BCBS), Medicare, Humana Health and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Debattista’s office at (650) 498-9111.

    Medical Specialties and Areas of Expertise

    Psychiatrist

    Education & Training

    Stanford Univ Hosp, Psychiatry (Residency)

    Stanford University Hospital (Residency)

    Stanford University Medical Center CA (Internship)

    Stanford University Medical Center (Residency)

    Stanford University Medical Center CA (Fellowship)

    Stanford University Program (Residency)

    Other Degree - University of Ca, San Francisco, Sch of Med, San Francisco Ca

    Medical Degree - University of California

    Board Certifications

    American Board of Psychiatry and Neurology

    American Board of Psychiatry and Neurology since 1995

    Insurances

    Top Insurances

    • Aetna

    • Blue Cross Blue Shield (BCBS)

    • Bravo Health

    • Cigna

    • Humana Health

    • Medicaid

    • Medicare

    • UnitedHealthcare

    View All Insurances

    Locations

    Lucile Packard Children's Hospital

    401 Quarry Rd

    Palo Alto, CA 94304

    (650) 498-9111

    Get Directions

    Recognitions

    Awards

    America's Best Doctors

    Psychiatry, Best Doctors

    Review Article of the Year, Primary Psychiatry

    Teacher of the Year, Dept. Of Psychiatry

    Publications

    Measuring severe adverse events

    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012

    The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression

    JOURL OF PSYCHIATRIC RESEARCH, 2011

    Safety considerations of the use of second generation antipsychotics

    Current drug safety, 2010

    Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function

    PSYCHONEUROENDOCRINOLOGY, 2009

    A multisite trial of mifepristone for the treatment of psychotic depression

    CONTEMPORARY CLINICAL TRIALS, 2009

    Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression

    CNS DRUGS, 2009

    Sildefil treatment of women with antidepressant-associated sexual dysfunction - A r

    JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION, 2008

    Depression and smoking cessation: does the evidence support psychiatric practice?

    Neuropsychiatric disease and treatment, 2007

    Modafinil augmentation of selective serotonin reuptake inhibitor therapy

    Anls of clinical psychiatry, 2007

    Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major

    BIOLOGICAL PSYCHIATRY, 2006

    The neuropsychological profile of psychotic major depression and its relation to cortisol

    BIOLOGICAL PSYCHIATRY, 2006

    The efficacy of mifepristone in the reduction

    BEHAVIOURAL BRAIN RESEARCH, 2006

    Augmentation and combition strategies for depression

    JOURL OF PSYCHOPHARMACOLOGY, 2006

    The use of mifepristone in the treatment of neuropsychiatric disorders

    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2006

    Modafinil augmentation of SSRI therapy in patients with major depressive disorder

    CNS SPECTRUMS, 2006

    Detecting psychotic major depression using psychiatric rating scales

    JOURL OF PSYCHIATRIC RESEARCH, 2006

    Update on augmentation of antidepressant response in resistant depression.

    Current psychiatry reports, 2005

    The efficacy of divalproex sodium in the treatment of agitation associated with major depression

    JOURL OF CLINICAL PSYCHOPHARMACOLOGY, 2005

    A placebo-controlled, randomized

    JOURL OF CLINICAL PSYCHIATRY, 2005

    C-1073 (mifepristone) in the adjunctive treatment of Alzheimer's disease.

    Current Alzheimer research, 2005

    Executive dysfunction in major depressive disorder.

    Expert review of neurotherapeutics, 2005

    A multicenter, placebo

    JOURL OF CLINICAL PSYCHIATRY, 2005

    HPA axis activation in major depression and response to fluoxetine: a pilot study

    PSYCHONEUROENDOCRINOLOGY, 2004

    A prospective trial of modafinil as an adjunctive treatment of major depression

    JOURL OF CLINICAL PSYCHOPHARMACOLOGY, 2004

    Seizure duration with remifentanil

    ACTA AESTHESIOLOGICA SCANDIVICA, 2003

    Adjunct modafinil for the short-term treatment of fatigue

    JOURL OF CLINICAL PSYCHIATRY, 2003

    Safety of antidepressants in the elderly.

    Expert opinion on drug safety, 2003

    A prospective trial of bupropion SR augmentation of partial

    JOURL OF CLINICAL PSYCHOPHARMACOLOGY, 2003

    The timing of electroconvulsive therapy

    JOURL OF CLINICAL ANESTHESIA, 2003

    Fetal heart rate decelerations during ECT-induced seizures: is it important?

    ACTA AESTHESIOLOGICA SCANDIVICA, 2003

    An open label trial of C-1073 (mifepristone) for psychotic major depression

    BIOLOGICAL PSYCHIATRY, 2002

    Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone

    JOURL OF MOLECULAR NEUROSCIENCE, 2002

    Cortisol feedback during the HPA quiescent period in patients with major depression

    AMERICAN JOURL OF PSYCHIATRY, 2001

    Is electroconvulsive therapy effective for the depressed patient

    JOURL OF ECT, 2001

    Sertraline versus imipramine to prevent relapse in chronic depression

    JOURL OF AFFECTIVE DISORDERS, 2001

    Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia

    ANLS OF INTERL MEDICINE, 2001

    Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients

    AMERICAN JOURL OF PSYCHIATRY, 2000

    24-hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major

    Posener, J. A., Debattista, C., Williams, G. H., Kraemer, H. C., Kaleh, 2000

    Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness

    AMERICAN JOURL OF PSYCHIATRY, 2000

    Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression

    JOURL OF CLINICAL PSYCHOPHARMACOLOGY, 2000

    Negative-pressure pulmory edema: A potential mazard in patients undergoing ECT

    JOURL OF ECT, 1999

    The Texas Medication Algorithm Project

    JOURL OF CLINICAL PSYCHIATRY, 1999

    Phenomenology and treatment of agitation

    Schatzberg, A. F., Debattista, C., 1999

    ECT in dissociative identity disorder and comorbid depression

    JOURL OF ECT, 1998

    Serotonergic synergism

    BIOLOGICAL PSYCHIATRY, 1998

    Developing treatment algorithms for unipolar depression in cyberspace

    PSYCHOPHARMACOLOGY BULLETIN, 1998

    Treatment of psychotic depression

    AMERICAN JOURL OF PSYCHIATRY, 1997

    Development of obsessive symptoms during nefazodone treatment

    AMERICAN JOURL OF PSYCHIATRY, 1996

    SUMATRIPTAN PROPHYLAXIS FOR POSTELECTROCONVULSIVE THERAPY HEADACHES

    HEADACHE, 1995

    PHYSICAL SYMPTOMS ASSOCIATED WITH PAROXETINE WITHDRAWAL

    AMERICAN JOURL OF PSYCHIATRY, 1995

    Frequently Asked Questions

    Is Dr. Charles Debattista accepting new patients?

    Yes, Dr. Charles Debattista is accepting new patients at this time.

    Does Dr. Charles Debattista offer online booking?

    Please contact Dr. Debattista's office at (650) 498-9111 for information about online booking, telehealth, or to schedule an appointment.

    Does Dr. Charles Debattista offer telehealth appointments?

    Please contact Dr. Debattista's office at (650) 498-9111 for information telehealth appointment availability or for scheduling assistance.

    Which language(s) does Dr. Charles Debattista speak?

    Dr. Charles Debattista speaks English.

    Which board certifications does Dr. Charles Debattista have?

    Dr. Charles Debattista is certified by the American Board of Psychiatry and Neurology.

    Other Psychiatrist Near Palo Alto, CA

    YX

    Psychiatrist
    LocationPin-icon
    725 Welch Rd, Palo Alto, CA 94304
    acceptingPatients-iconAccepting patients

    VC

    Psychiatrist
    LocationPin-icon
    401 Quarry Rd, Palo Alto, CA 94304
    acceptingPatients-iconAccepting patients
    Dr. David D Hong, MD
    Psychiatrist
    LocationPin-icon
    401 Quarry Rd, Palo Alto, CA 94304
    acceptingPatients-iconAccepting patients
    See All Specialists

    Doctors by Category

    Specialists